Charles Schwab’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-225,272
| Closed | -$16.2M | – | 3560 |
|
|
2020
Q4 | $16.2M | Buy |
225,272
+1,987
| +0.9% | +$104K | 0.01% | 1553 |
|
|
2020
Q3 | $10.2M | Sell |
223,285
-2,469
| -1% | -$103K | ﹤0.01% | 1686 |
|
|
2020
Q2 | $10.2M | Buy |
225,754
+12,901
| +6% | +$578K | 0.01% | 1640 |
|
|
2020
Q1 | $8.2M | Buy |
212,853
+3,730
| +2% | +$172K | ﹤0.01% | 1572 |
|
|
2019
Q4 | $9.68M | Buy |
209,123
+7,457
| +4% | +$323K | 0.01% | 1684 |
|
|
2019
Q3 | $8.21M | Buy |
201,666
+5,991
| +3% | +$259K | ﹤0.01% | 1716 |
|
|
2019
Q2 | $9.42M | Buy |
195,675
+5,048
| +3% | +$265K | 0.01% | 1625 |
|
|
2019
Q1 | $11.9M | Buy |
190,627
+8,867
| +5% | +$609K | 0.01% | 1471 |
|
|
2018
Q4 | $10.9M | Buy |
181,760
+2,358
| +1% | +$142K | 0.01% | 1404 |
|
|
2018
Q3 | $11.6M | Buy |
179,402
+16,154
| +10% | +$901K | 0.01% | 1545 |
|
|
2018
Q2 | $7.35M | Buy |
163,248
+15,139
| +10% | +$604K | 0.01% | 1794 |
|
|
2018
Q1 | $4.6M | Buy |
148,109
+7,475
| +5% | +$246K | ﹤0.01% | 1991 |
|
|
2017
Q4 | $4.21M | Buy |
140,634
+13,962
| +11% | +$404K | ﹤0.01% | 2013 |
|
|
2017
Q3 | $4.18M | Buy |
126,672
+14,238
| +13% | +$493K | ﹤0.01% | 1967 |
|
|
2017
Q2 | $3.76M | Sell |
112,434
-13,336
| -11% | -$398K | ﹤0.01% | 1958 |
|
|
2017
Q1 | $3.64M | Buy |
125,770
+7,140
| +6% | +$177K | ﹤0.01% | 1940 |
|
|
2016
Q4 | $2.65M | Buy |
118,630
+13,771
| +13% | +$269K | ﹤0.01% | 2051 |
|
|
2016
Q3 | $1.95M | Buy |
104,859
+66,159
| +171% | +$1.25M | ﹤0.01% | 2140 |
|
|
2016
Q2 | $631K | Hold |
38,700
| – | – | ﹤0.01% | 2511 |
|
|
2016
Q1 | $453K | Hold |
38,700
| – | – | ﹤0.01% | 2616 |
|
|
2015
Q4 | $453K | Hold |
38,700
| – | – | ﹤0.01% | 2688 |
|
|
2015
Q3 | $474K | Hold |
38,700
| – | – | ﹤0.01% | 2645 |
|
|
2015
Q2 | $365K | Hold |
38,700
| – | – | ﹤0.01% | 2796 |
|
|
2015
Q1 | $343K | Hold |
38,700
| – | – | ﹤0.01% | 2784 |
|
|
2014
Q4 | $389K | Hold |
38,700
| – | – | ﹤0.01% | 2732 |
|
|
2014
Q3 | $260K | Hold |
38,700
| – | – | ﹤0.01% | 2865 |
|
|
2014
Q2 | $278K | Buy |
+38,700
| New | +$308K | ﹤0.01% | 2889 |
|
Other funds holding BEAT
Charles Schwab's BEAT Position: Q1 2021 in Review
Charles Schwab sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 225,272 shares — an estimated $16.2M sold.
Charles Schwab first reported a position in BEAT in Q2 2014 and held it in 27 quarters. The position peaked at $16.2M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Charles Schwab reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Charles Schwab sold 225,272 BioTelemetry, Inc. shares in Q1 2021, an estimated $16.2M.
- Charles Schwab first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 27 quarters.
- Charles Schwab's BioTelemetry, Inc. position peaked at $16.2M in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.